您的购物车当前为空
Hesperadin 是 Aurora A 和 B 的 ATP 竞争性吲哚酮抑制剂,抑制 Aurora B 的 IC50值为250nM。它通过阻断核分裂和胞质分裂而抑制布鲁氏锥虫的生长。它也是一种广谱流感抗病毒剂。

Hesperadin 是 Aurora A 和 B 的 ATP 竞争性吲哚酮抑制剂,抑制 Aurora B 的 IC50值为250nM。它通过阻断核分裂和胞质分裂而抑制布鲁氏锥虫的生长。它也是一种广谱流感抗病毒剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 292 | In Stock | |
| 2 mg | ¥ 413 | In Stock | |
| 5 mg | ¥ 662 | In Stock | |
| 10 mg | ¥ 1,090 | In Stock | |
| 25 mg | ¥ 2,180 | 待询 | |
| 50 mg | ¥ 3,480 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 752 | 待询 |
Hesperadin 相关产品
| 产品描述 | Hesperadin(IC50=250 nM) effectively inhibits Aurora B. It potently reduces the activity of AMPK, MAPKAP-K1, MKK1, Lck, CHK1 and PHK, but it could not inhibit MKK1 activity in vivo. |
| 靶点活性 | Aurora B:250 nM |
| 体外活性 | 在HeLa细胞中,Hesperadin通过抑制Aurora B的功能,干扰染色体连接,造成有丝分裂和细胞质分裂缺陷,导致细胞增殖停止和多倍体化。Hesperadin在20-100 nM浓度作用下,导致有丝分裂活化组蛋白H3在Ser10位点的磷酸化丢失。当Hesperadin浓度达到1 μM时,其他激酶(AMPK, Lck, MKK1, MAPKAP-K1, CHK1, 和 PHK)活性显著降低。在体外激酶测定中,Hesperadin(IC50 = 40 nM)阻断了来自病原性锥虫(Trypanosoma brucei)的TbAUK1(T. brucei Aurora kinase-1)对重组色质组蛋白H3的磷酸化。Hesperadin(IC50 = 48 nM)显著抑制了培养的传染性血液形式(BF)细胞的生长,而以IC50 = 550 nM的浓度弱抑制了昆虫循环阶段(PF)细胞的生长。 |
| 激酶实验 | For the Aurora B kinase assay, HeLa cells are lysed in a buffer containing 50 mM NaCl, then centrifuging at 13,000 rpm for 20 minutes at 4 °C. Discard supernatant, add 15 mL lysis buffer containing 250 mM NaCl in order to obtain active Aurora B kinase. Centrifuging at low-speed supernatant of the latter extract is used for immunoprecipitation. Monoclonal mouse anti–AIM-1, or mouse anti-HA, is coupled to GammaBind Plus Sepharose, and beads are rotated over-end in the extract for 90 minutes at 4 °C. Beads are washed, aliquoted, and washed in kinase buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 1 mM DTT, 10 mM NaF). The kinase assay is performed with 10 μL beads in 20 μL kinase buffer containing 5 μg histone H3, 10 μM ATP, 2.5 μCi [γ-32P]ATP, and different concentrations of Hesperadin for 20 minutes at 37 °C. |
| 细胞实验 | HeLa cells and PtK1 cells are added Hesperadin 500 nM for 24 and 48 hours. |
| 分子量 | 516.65 |
| 分子式 | C29H32N4O3S |
| CAS No. | 422513-13-1 |
| Smiles | CCS(=O)(=O)Nc1ccc2NC(=O)\C(=C(/Nc3ccc(CN4CCCCC4)cc3)c3ccccc3)c2c1 |
| 密度 | 1.326 g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55.3 mg/mL (107.04 mM), Sonication is recommended. Ethanol: 27.7 mg/mL (53.61 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.87 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容